New York State Common Retirement Fund’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

New York State Common Retirement Fund’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-48,323	Closed	-$203K	–	3498
2023 Q1	$203K	Sell	48,323 -16,430	-25%	-$85.3K	﹤0.01%	2581
2022 Q4	$389K	Buy	64,753 +53	+0.1%	+$289	﹤0.01%	2438
2022 Q3	$377K	Buy	64,700 +800	+1%	+$4.99K	﹤0.01%	2480
2022 Q2	$381K	Buy	+63,900	New	+$327K	﹤0.01%	2483
2019 Q2	–	Sell	-37,300	Closed	-$36K	–	3385
2019 Q1	$36K	Hold	37,300	–	–	﹤0.01%	3102
2018 Q4	$27K	Hold	37,300	–	–	﹤0.01%	3143
2018 Q3	$81K	Hold	37,300	–	–	﹤0.01%	3076
2018 Q2	$186K	Buy	+37,300	New	+$163K	﹤0.01%	2902
2016 Q2	–	Sell	-15,040	Closed	-$80K	–	3273
2016 Q1	$80K	Hold	15,040	–	–	﹤0.01%	2983
2015 Q4	$185K	Hold	15,040	–	–	﹤0.01%	2805
2015 Q3	$220K	Sell	15,040 -2,460	-14%	-$42.5K	﹤0.01%	2742
2015 Q2	$341K	Buy	+17,500	New	+$338K	﹤0.01%	2702

Other funds holding CTIC

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

New York State Common Retirement Fund's CTIC Position: Q2 2023 in Review

New York State Common Retirement Fund sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 48,323 shares — an estimated $203K sold.

New York State Common Retirement Fund first reported a position in CTIC in Q2 2015 and held it in 12 quarters. The position peaked at $389K in Q4 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

New York State Common Retirement Fund reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
New York State Common Retirement Fund sold 48,323 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $203K.
New York State Common Retirement Fund first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2015 and held it in 12 quarters.
New York State Common Retirement Fund's CTI BioPharma Corp. (DE) Common Stock position peaked at $389K in Q4 2022.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on New York State Common Retirement Fund's 13F filing for Q2 2023, filed 7 Aug 2023.